Article

Clinical Outcomes of Patients Previously Treated with B-Cell Depletion Therapy Hospitalized with COVID-19: Results from the Johns Hopkins Crown Registry

2022-03-11

Abstract excerpt

Background: Biologic therapies that target B-cell function are effective for a range of medical conditions. Patients treated with such therapies do not reliably generate robust humoral responses which may increase their risk for severe viral infections, including SARS-CoV2.This study sought to characterize outcomes for patients previously treated with B-cell depleting drugs who were hospitalized with COVID-19 co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e3623b48-5825-51ac-aece-2fcff55a6f2c
DOI: 10.2139/ssrn.4030554

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical Outcomes of Patients Previously Treated with B-Cell Depletion Therapy Hospitalized with COVID-19: Results from the Johns Hopkins Crown RegistryDOI 10.2139/ssrn.4030554Read

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort StudySemantic proximity Read

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron EraSemantic proximity Read

Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trialSemantic proximity Read

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerSemantic proximity Read

Association of Convalescent Plasma Treatment with Reduced Mortality and Improved Clinical Trajectory in Patients Hospitalized with COVID-19 in the Community SettingSemantic proximity Read

Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 OutpatientsSemantic proximity Read

Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patientsSemantic proximity Read

Factors Associated with Mortality Among 4,227 Patients with COVID-19 in Massachusetts: A Retrospective Cohort StudySemantic proximity Read

Immune targeted therapies for COVID-19 Infection: A Promising OutlookSemantic proximity Read

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendationsSemantic proximity Read

SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolismSemantic proximity Read

Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity Read